Shrewsbury, MA, United States of America

Srinivasarao Meneni

This inventor holds 1 USPTO granted patent. Top assignee: Selectx Pharmaceuticals, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivasarao Meneni. Retrieved from https://idiyas.com/inventor/srinivasarao-meneni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Srinivasarao Meneni

Introduction

Srinivasarao Meneni is a notable inventor based in Shrewsbury, MA, who has made significant contributions to the field of antibiotics. His work primarily focuses on developing new compounds that can effectively combat bacterial infections, especially those resistant to existing treatments.

Latest Patents

Meneni holds a patent for "4,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics." This innovative antibiotic formula is designed to treat bacterial infections, providing a new avenue for patients suffering from resistant strains. The patent highlights the importance of his research in addressing critical healthcare challenges.

Career Highlights

Meneni is associated with Selectx Pharmaceuticals, Inc., where he applies his expertise in antibiotic development. His work at the company underscores his commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Some of his notable coworkers include Michael G Chaparian and Michael Brady, who contribute to the collaborative environment at Selectx Pharmaceuticals. Their combined efforts enhance the research and development of new therapeutic options.

Conclusion

Srinivasarao Meneni's contributions to antibiotic innovation are vital in the ongoing battle against resistant bacterial infections. His work exemplifies the impact of dedicated research in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…